Takeda is sharpening its oncology focus amid an R&D revamp. Sun Pharma will acquire Checkpoint Therapeutics and an ...

Bigger companies can seek funding of up to ₹125 crore while startups can secure funding of ₹1 crore, over a period of five ...

R&amp,D outsourcing involves pharmaceutical companies subcontracting parts of their R&amp,D efforts to third-party service providers. Small or mid-sized pharmaceutical or biotech houses may use ...

Quoted Finnish pharmaceutical company Orion Corporation is establishing a new research & development centre in Cambridge to ...

India aims for Rs 17,000 crore investment in pharma R&D by FY28 through PRIP scheme, focusing on innovation and growth.

Dr. Anatoly Dritschilo remains Chairman of the Board and Co-CEO overseeing scientific and clinical trial activities.

NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it has entered into an agreement with Biogen to provide research and development (R&D ...

Robert Lenz is leaving the brain drug developer to “pursue other interests.” Elsewhere, Atara is cutting half of its staff ...

With grant funding from governments at multiple levels in Canada, Entos Pharmaceuticals is looking to plant roots at a CAD $198.5 million ($137.2 million) R&D and manufacturing hub in Edmonton. | The ...

Indian pharmaceutical companies may have units abroad as part of 'distributed manufacturing' across various locations, ...

The USFDA has established an office in India to oversee the number of Indian manufacturers qualified to supply generic ...